Arbutus Biopharma Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.32 |
Market Cap |
$127.91 M |
Shares Outstanding |
56.85 M |
Public Float |
33.5 M |
Address |
8900 Glenlyon Parkway Burnaby British Columbia V5J 5J8 Canada |
Employees | - |
Website | http://www.arbutusbio.com |
Updated | 07/08/2019 |
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. . |